British Association of Dermatologists (BAD) National Audit on Non-Melanoma Skin Cancer Excision 2016 in collaboration with the Royal College of Pathologists.
Carcinoma, Basal Cell
/ surgery
Carcinoma, Squamous Cell
/ surgery
Clinical Audit
Dermatologic Surgical Procedures
/ statistics & numerical data
Dermatologists
Margins of Excision
Pathologists
Practice Patterns, Physicians'
/ statistics & numerical data
Skin Neoplasms
/ diagnosis
Societies, Medical
United Kingdom
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
accepted:
27
06
2019
pubmed:
3
7
2019
medline:
19
5
2020
entrez:
3
7
2019
Statut:
ppublish
Résumé
We conducted a re-audit of the surgical practice of UK dermatologists for the treatment of nonmelanoma skin cancer and examined changes with reference to our previous audit in 2014. The audit was supplemented by a detailed assessment of completeness of the histopathology reports for each tumour. UK dermatologists collected data on 10 consecutive nonmicrographic excisions for basal cell carcinoma (BCC) and 5 for squamous cell carcinoma (SCC). Data were collected on site, preoperative diagnosis, histological diagnosis, proximity to previous scars, and histological deep and peripheral margins. In total, 222 responses were received from 135 centres, reporting on 3290 excisions. Excisions from the head and neck accounted for 56.7% of cases. Tumour diameter (mean ± SD) was 11.4 ± SD 7.1 mm (maximum size 100 mm) and 97% of cases were primary excisions. BCCs and SCCs respectively accounted for 65.7% and 26.8% of total cases. Of the suspected BCCs and SCCs, 95.8% and 80.4%, respectively, were confirmed histologically. All margins for any tumour were clear in 97.0% of cases, and complication rate in the audit was < 1%. Of the 2864 histology reports evaluated, only 706 (24.6%) contained all core data items; 95% of these were structure (synoptic) reports. Commonly omitted items were level of invasion, risk and T stage, which were absent from 35.7%, 64.2% and 44.1% of reports, respectively. Diagnostic accuracy and complete excision rates remain high. Complication rates may be under-reported owing to lack of follow-up. Histopathology reporting has a greater chance of being complete if reports are generated on a field-based platform (synoptic reporting).
Sections du résumé
BACKGROUND
BACKGROUND
We conducted a re-audit of the surgical practice of UK dermatologists for the treatment of nonmelanoma skin cancer and examined changes with reference to our previous audit in 2014. The audit was supplemented by a detailed assessment of completeness of the histopathology reports for each tumour.
METHODS
METHODS
UK dermatologists collected data on 10 consecutive nonmicrographic excisions for basal cell carcinoma (BCC) and 5 for squamous cell carcinoma (SCC). Data were collected on site, preoperative diagnosis, histological diagnosis, proximity to previous scars, and histological deep and peripheral margins.
RESULTS
RESULTS
In total, 222 responses were received from 135 centres, reporting on 3290 excisions. Excisions from the head and neck accounted for 56.7% of cases. Tumour diameter (mean ± SD) was 11.4 ± SD 7.1 mm (maximum size 100 mm) and 97% of cases were primary excisions. BCCs and SCCs respectively accounted for 65.7% and 26.8% of total cases. Of the suspected BCCs and SCCs, 95.8% and 80.4%, respectively, were confirmed histologically. All margins for any tumour were clear in 97.0% of cases, and complication rate in the audit was < 1%. Of the 2864 histology reports evaluated, only 706 (24.6%) contained all core data items; 95% of these were structure (synoptic) reports. Commonly omitted items were level of invasion, risk and T stage, which were absent from 35.7%, 64.2% and 44.1% of reports, respectively.
CONCLUSIONS
CONCLUSIONS
Diagnostic accuracy and complete excision rates remain high. Complication rates may be under-reported owing to lack of follow-up. Histopathology reporting has a greater chance of being complete if reports are generated on a field-based platform (synoptic reporting).
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
48-55Informations de copyright
© 2019 British Association of Dermatologists.
Références
National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma. Available at: https://www.nice.org.uk/guidance/csgstim/evidence/improving-outcomes-for-people-with-skin-tumours-including-melanoma-the-manual-2006-guidance2 (accessed April 2015).
Telfer NR, Colver GB, Morton CA, British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British Association of Dermatologists Available at: http://www.bad.org.uk/shared/get-file.ashx?xml:id=59&itemtype=document (accessed 11 April, 2015).
Motley R, Kersey P, Lawrence C et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18-25.
Matteucci P, Pinder R, Magdum A, Stanley P. Accuracy in skin lesion diagnosis and the exclusion of malignancy. J Plast Reconstr Aesthet Surg 2011; 64: 1460-5.
Ahnlide I, Bjellerup M. Accuracy of clinical skin tumour diagnosis in a dermatological setting. Acta Derm Venereol 2013; 93: 305-8.
Fremlin GA, Bray AP, de Berker DA. Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system. Clin Exp Dermatol 2014; 39: 689-95.
Bariani RL, Nahas FX, Barbosa MVJ et al. Basal cell carcinoma: an updated epidemiological and therapeutic profile of an urban population. Acta Cir Bras 2006; 21: 66-73.
Haque Hussain SS, Shams N, Garioch JJ. Managing squamous cell carcinomas: audit on the mode of referral and adequacy of surgical excision. Br J Dermatol 2009; 160: 224-5.
Delaney EK, Duckworth L, Thompson WD et al. Excising squamous cell carcinomas: comparing the performance of GPs, hospital skin specialists and other hospital specialists. Fam Pract 2012; 29: 541-6.
Gudi V, Ormerod AD, Dawn G, et al. Management of basal cell carcinoma by surveyed dermatologists in Scotland. Clin Exp Dermatol 2006; 31: 648-52.
Macbeth AE, Torley D, Casie Chetty N. , et al. Audit of incomplete excision rates of basal cell carcinoma: analysis of 1972 cases from four U.K. regions. Br J Dermatol 2009; 161: 710-12.
Cho M, Lee J, James CL et al. Scalp basal cell carcinoma: review of 2,202 cases. Dermatol Surg 2016; 42: 834-41.
Malik V, Goh KS, Leong S et al. Risk and outcome analysis of 1832 consecutively excised basal cell carcinomas in a tertiary referral plastic surgery unit. J Plast Reconstr Aesthet Surg 2010; 63: 2057-63.
Dhepnorrarat RC, Lee MA,Mountain JA. Incompletely excised skin cancer rates: a prospective study of 31 731 skin cancer excisions by the Western Australian Society of Plastic Surgeons. J Plast Reconstr Aesthet Surg 2009; 62: 1281-5.